InterveXion Therapeutics
Binding methamphetamine to release people from addiction
Binding methamphetamine to release people from addiction
InterveXion Therapeutics is a biotechnology startup founded in 2004 and based in the United States. The company's mission is encapsulated in its slogan, "Binding methamphetamine to release people from addiction." Specializing in the development of therapies for substance use disorders, InterveXion Therapeutics has garnered attention from investors, with its most recent $13.80M grant investment coming from the National Institutes of Health in November 2021. The company operates in the biopharma, biotechnology, health care, and pharmaceutical industries. With promising advancements in addiction treatment, InterveXion Therapeutics presents a compelling opportunity for investors seeking to support innovative solutions in the healthcare sector.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Grant | $13.80M | 1 | National Institutes of Health | 01 Nov 2021 |
| Grant | $8.10M | 2 |
-logo.jpg){kind=logo}
|
05 Oct 2020 |
| Grant | $8.40M | 2 |
|
05 May 2020 |
| Grant | $8.00M | 2 |
|
10 Oct 2017 |
| Grant | $14.50M | 2 |
|
29 Jan 2015 |
No recent news or press coverage available for InterveXion Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
